Navigation path

Community Register of medicinal products

Community list of not active orphan medicinal products
WITHDRAWN  

Product information

Nanoparticle albumin-bound paclitaxel

EU orphan designation number: EU/3/10/809
Active ingredient: Nanoparticle albumin-bound paclitaxel
Indication: Treatment of pancreatic cancer
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Centralised Orphan - Designation EMA/OD/087/10 (2010)8594 of 26/11/2010
01/09/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/087/10/T/01 (2011)6291 of 30/08/2011
07/02/2013 Centralised Orphan - Removal of orphan designation from Community Register